Kovack Advisors, Inc. Becton Dickinson & CO Transaction History

Kovack Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$232.24 - $267.23 $157,458 - $181,181	-678 Reduced 44.28%	853 $207,000
Q3 2023 Oct 19, 2023	SELL	$254.9 - $283.59 $1,784 - $1,985	-7 Reduced 0.46%	1,531 $395,000
Q2 2023 Jul 21, 2023	BUY	$238.39 - $265.32 $366,643 - $408,062	1,538 New	1,538 $406,000
Q1 2021 May 04, 2021	SELL	$232.09 - $256.88 $286,166 - $316,733	-1,233 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$221.92 - $245.94 $4,438 - $4,918	-20 Reduced 1.6%	1,233 $309,000
Q3 2020 Nov 02, 2020	BUY	$215.77 - $276.76 $4,315 - $5,535	20 Added 1.62%	1,253 $291,000
Q2 2020 Jul 31, 2020	SELL	$219.9 - $263.41 $27,487 - $32,926	-125 Reduced 9.2%	1,233 $295,000
Q1 2020 Apr 30, 2020	BUY	$195.69 - $279.01 $14,872 - $21,204	76 Added 5.93%	1,358 $312,000
Q4 2019 Jan 29, 2020	BUY	$236.45 - $266.82 $65,023 - $73,375	275 Added 27.31%	1,282 $349,000
Q3 2019 Oct 31, 2019	SELL	$230.58 - $256.08 $4,381 - $4,865	-19 Reduced 1.85%	1,007 $255,000
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $223,052 - $252,478	1,026 New	1,026 $259,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.